Bendamustine: An old drug for a potential new indication!-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Bendamustine: An old drug for a potential new indication!

Published:2023 Issue:1 Volume:6 Page:156-158
ISSN:2590-3233
Container-title:Cancer Research, Statistics, and Treatment
language:en
Short-container-title:

Author:

Kirar Sudhir K.,Suri Oshin,Kumar Lalit

Publisher

Medknow

Subject

Cancer Research,Oncology (nursing),Drug Guides,Ophthalmology

Reference17 articles.

1. Bendamustine;Balfour;Drugs,2001

2. Randomized trial of bendamustine-rituximab or R-CHOP/R-CVP in first-line treatment of indolent NHL or MCL: The BRIGHT study;Flinn;Blood,2014

3. Treatment of bendamustine and prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with melphalan and prednisone--A randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO);Pönisch;J Cancer Res Clin Oncol,2006

4. Bendamustine in combination with pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: A phase II trial;Kumar;Br J Haematol,2022

5. Bendamustine as salvage treatment in patients with advanced progressive breast cancer: A phase II study;Höffken;J Cancer Res Clin Oncol,1998

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Authors’ reply to Kirar et al. and Chaudhuri;Cancer Research, Statistics, and Treatment;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP